Chugai Applies For Additional Indication For Avastin In Japan
This article was originally published in PharmAsia News
Executive Summary
Roche Japanese unit Chugai Pharmaceutical announced Oct. 16 it applied for an additional indication of breast cancer forAvastin (bevacizumab)